BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18566322)

  • 1. Leukemic transformation in mice expressing a NUP98-HOXD13 transgene is accompanied by spontaneous mutations in Nras, Kras, and Cbl.
    Slape C; Liu LY; Beachy S; Aplan PD
    Blood; 2008 Sep; 112(5):2017-9. PubMed ID: 18566322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling and candidate gene resequencing identifies pathways and mutations important for malignant transformation caused by leukemogenic fusion genes.
    Novak RL; Harper DP; Caudell D; Slape C; Beachy SH; Aplan PD
    Exp Hematol; 2012 Dec; 40(12):1016-27. PubMed ID: 22885519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of p53 accelerates the complications of myelodysplastic syndrome in a NUP98-HOXD13-driven mouse model.
    Xu H; Menendez S; Schlegelberger B; Bae N; Aplan PD; Göhring G; Deblasio TR; Nimer SD
    Blood; 2012 Oct; 120(15):3089-97. PubMed ID: 22927245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CBL exon 8/9 mutants activate the FLT3 pathway and cluster in core binding factor/11q deletion acute myeloid leukemia/myelodysplastic syndrome subtypes.
    Reindl C; Quentmeier H; Petropoulos K; Greif PA; Benthaus T; Argiropoulos B; Mellert G; Vempati S; Duyster J; Buske C; Bohlander SK; Humphries KR; Hiddemann W; Spiekermann K
    Clin Cancer Res; 2009 Apr; 15(7):2238-47. PubMed ID: 19276253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retroviral insertional mutagenesis identifies genes that collaborate with NUP98-HOXD13 during leukemic transformation.
    Slape C; Hartung H; Lin YW; Bies J; Wolff L; Aplan PD
    Cancer Res; 2007 Jun; 67(11):5148-55. PubMed ID: 17545593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depletion of cytotoxic T-cells does not protect NUP98-HOXD13 mice from myelodysplastic syndrome but reveals a modest tumor immunosurveillance effect.
    Gough SM; Chung YJ; Aplan PD
    PLoS One; 2012; 7(5):e36876. PubMed ID: 22606303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A high occurrence of acquisition and/or expansion of C-CBL mutant clones in the progression of high-risk myelodysplastic syndrome to acute myeloid leukemia.
    Kao HW; Sanada M; Liang DC; Lai CL; Lee EH; Kuo MC; Lin TL; Shih YS; Wu JH; Huang CF; Ogawa S; Shih LY
    Neoplasia; 2011 Nov; 13(11):1035-42. PubMed ID: 22131879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress leads to increased mutation frequency in a murine model of myelodysplastic syndrome.
    Chung YJ; Robert C; Gough SM; Rassool FV; Aplan PD
    Leuk Res; 2014 Jan; 38(1):95-102. PubMed ID: 23958061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NUP98-HOX translocations lead to myelodysplastic syndrome in mice and men.
    Slape C; Lin YW; Hartung H; Zhang Z; Wolff L; Aplan PD
    J Natl Cancer Inst Monogr; 2008; (39):64-8. PubMed ID: 18648006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant
    Goldberg L; Negi V; Chung YJ; Onozawa M; Zhu YJ; Walker RL; Pierce R; Patel DP; Krausz KW; Gonzalez FJ; Goodell MA; Rodriguez BAT; Meltzer PS; Aplan PD
    Cancer Res; 2021 Oct; 81(19):5033-5046. PubMed ID: 34321240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SETD2 deficiency accelerates MDS-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in MDS.
    Chen BY; Song J; Hu CL; Chen SB; Zhang Q; Xu CH; Wu JC; Hou D; Sun M; Zhang YL; Liu N; Yu PC; Liu P; Zong LJ; Zhang JY; Dai RF; Lan F; Huang QH; Zhang SJ; Nimer SD; Chen Z; Chen SJ; Sun XJ; Wang L
    Blood; 2020 Jun; 135(25):2271-2285. PubMed ID: 32202636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive genomic instability in the Nup98-HoxD13 model of MDS correlates with loss of the PIG-A gene product.
    Byrne M; Bennett RL; Cheng X; May WS
    Neoplasia; 2014 Aug; 16(8):627-33. PubMed ID: 25220590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia.
    Lin YW; Slape C; Zhang Z; Aplan PD
    Blood; 2005 Jul; 106(1):287-95. PubMed ID: 15755899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PUMA promotes apoptosis of hematopoietic progenitors driving leukemic progression in a mouse model of myelodysplasia.
    Guirguis AA; Slape CI; Failla LM; Saw J; Tremblay CS; Powell DR; Rossello F; Wei A; Strasser A; Curtis DJ
    Cell Death Differ; 2016 Jun; 23(6):1049-59. PubMed ID: 26742432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of apoptosis by BCL2 prevents leukemic transformation of a murine myelodysplastic syndrome.
    Slape CI; Saw J; Jowett JB; Aplan PD; Strasser A; Jane SM; Curtis DJ
    Blood; 2012 Sep; 120(12):2475-83. PubMed ID: 22855610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brief report: Loss of p15Ink4b accelerates development of myeloid neoplasms in Nup98-HoxD13 transgenic mice.
    Humeniuk R; Koller R; Bies J; Aplan P; Wolff L
    Stem Cells; 2014 May; 32(5):1361-6. PubMed ID: 24449168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymic precursor cells generate acute myeloid leukemia in NUP98-PHF23/NUP98-HOXD13 double transgenic mice.
    Kundu S; Park ES; Chung YJ; Walker RL; Zhu YJ; Negi V; Meltzer PS; Aplan PD
    Sci Rep; 2019 Nov; 9(1):17213. PubMed ID: 31748606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of acute myeloid leukemia in mice by the human leukemia-specific fusion gene NUP98-HOXD13 in concert with Meis1.
    Pineault N; Buske C; Feuring-Buske M; Abramovich C; Rosten P; Hogge DE; Aplan PD; Humphries RK
    Blood; 2003 Jun; 101(11):4529-38. PubMed ID: 12543865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NUP98-HOXA9-transgenic zebrafish develop a myeloproliferative neoplasm and provide new insight into mechanisms of myeloid leukaemogenesis.
    Forrester AM; Grabher C; McBride ER; Boyd ER; Vigerstad MH; Edgar A; Kai FB; Da'as SI; Payne E; Look AT; Berman JN
    Br J Haematol; 2011 Oct; 155(2):167-81. PubMed ID: 21810091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detectable FLT3-ITD or RAS mutation at the time of transformation from MDS to AML predicts for very poor outcomes.
    Badar T; Patel KP; Thompson PA; DiNardo C; Takahashi K; Cabrero M; Borthakur G; Cortes J; Konopleva M; Kadia T; Bohannan Z; Pierce S; Jabbour EJ; Ravandi F; Daver N; Luthra R; Kantarjian H; Garcia-Manero G
    Leuk Res; 2015 Dec; 39(12):1367-74. PubMed ID: 26547258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.